Brown, Lisle/Cummings’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $643K | Buy |
45,112
+852
| +2% | +$12.2K | 0.17% | 121 |
|
2025
Q1 | $659K | Buy |
44,260
+1,549
| +4% | +$23.1K | 0.19% | 118 |
|
2024
Q4 | $615K | Buy |
42,711
+6,198
| +17% | +$89.3K | 0.18% | 119 |
|
2024
Q3 | $578K | Buy |
36,513
+2,128
| +6% | +$33.7K | 0.18% | 120 |
|
2024
Q2 | $528K | Sell |
34,385
-1,311
| -4% | -$20.1K | 0.17% | 126 |
|
2024
Q1 | $585K | Buy |
35,696
+1,063
| +3% | +$17.4K | 0.2% | 113 |
|
2023
Q4 | $507K | Buy |
34,633
+9,671
| +39% | +$142K | 0.19% | 119 |
|
2023
Q3 | $360K | Buy |
24,962
+1,250
| +5% | +$18K | 0.16% | 131 |
|
2023
Q2 | $389K | Buy |
23,712
+292
| +1% | +$4.8K | 0.17% | 128 |
|
2023
Q1 | $391K | Buy |
23,420
+89
| +0.4% | +$1.49K | 0.2% | 117 |
|
2022
Q4 | $360K | Buy |
23,331
+1,090
| +5% | +$16.8K | 0.19% | 118 |
|
2022
Q3 | $332K | Sell |
22,241
-402
| -2% | -$6K | 0.19% | 109 |
|
2022
Q2 | $372K | Buy |
22,643
+1,555
| +7% | +$25.5K | 0.21% | 110 |
|
2022
Q1 | $423K | Buy |
21,088
+15,267
| +262% | +$306K | 0.2% | 111 |
|
2021
Q4 | $148K | Buy |
+5,821
| New | +$148K | 0.07% | 183 |
|